Effect of thiolated polymers to textural and mucoadhesive properties of vaginal gel formulations prepared with polycarbophil and chitosan.
The aim of this study was to design and evaluate of mucoadhesive gel formulations for the vaginal application of clomiphene citrate (CLM) for local treatment of human papilloma virus (HPV) infections. Chitosan (CHI) and polycarbophil (PC) were covalently modified using the thioglycolic acid and L-cysteine, respectively. The formation of thiol conjugates of chitosan (CHI-TG) and polycarbophil (PC-CYS) were confirmed by FT-IR analysis and PC-CYS and CHI-TG were found to have 148.42 +/- 4.16 and 41.17 +/- 2.34 micromol of thiol groups per gram of polymer, respectively. One percent CLM gels were prepared by combination of various concentrations of PC and CHI with thiolated conjugates of these polymers. Hardness, compressibility, elasticity, adhesiveness and cohesiveness of the gels were measured by Texture profile analysis and the vaginal mucoadhesion was investigated by mucoadhesion test. The increasing in the amount of the thiol conjugates was found to enhance the elasticity, cohesiveness, adhesiveness and mucoadhesion of the gel formulations but not their hardness and compressibility when compared to gels prepared using their respective parent formulations. Slower release rate of CLM from gels was achieved when the polymer concentrations were increased in the gel formulations. PC and its thiol conjugate were found to prolong the release of CLM longer than 70 h unlike gel formulations prepared using CHI and its thiol conjugate which were able to release CLM up to 12 h. Stability of CLM was preserved during the 3 month stability analysis under controlled room temperature and accelerated conditions.
Cevher
Erdal
E
Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul University, 34116, Istanbul, Turkey. ecevher@istanbul.edu.tr
Sensoy
Demet
D
Taha
Mohamed A M
MA
Araman
Ahmet
A
D000180:Acrylic Resins / Q000737:chemistry* / Q000493:pharmacokinetics; D000269:Adhesives / Q000737:chemistry* / Q000493:pharmacokinetics; D002626:Chemistry, Pharmaceutical; D048271:Chitosan / Q000737:chemistry* / Q000493:pharmacokinetics; D019245:Compressive Strength; D003218:Condylomata Acuminata / Q000188:drug therapy / Q000821:virology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D027383:Papillomaviridae / Q000187:drug effects / Q000254:growth & development; D011108:Polymers / Q000737:chemistry* / Q000493:pharmacokinetics; D013438:Sulfhydryl Compounds / Q000737:chemistry* / Q000493:pharmacokinetics; D014622:Vaginal Creams, Foams, and Jellies / Q000737:chemistry* / Q000493:pharmacokinetics
D000180:Acrylic Resins; D000269:Adhesives; D011108:Polymers; D013438:Sulfhydryl Compounds; D014622:Vaginal Creams, Foams, and Jellies; C030312:calcium polycarbophil; D048271:Chitosan